These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34472721)

  • 1. Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma.
    Miyagaki S; Kikuchi K; Mori J; Lopaschuk GD; Iehara T; Hosoi H
    Cancer Med; 2021 Sep; 10(18):6442-6455. PubMed ID: 34472721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
    Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors.
    Cheng JF; Chen M; Wallace D; Tith S; Haramura M; Liu B; Mak CC; Arrhenius T; Reily S; Brown S; Thorn V; Harmon C; Barr R; Dyck JR; Lopaschuk GD; Nadzan AM
    J Med Chem; 2006 Mar; 49(5):1517-25. PubMed ID: 16509570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
    Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
    J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of central ghrelin on fatty acid metabolism in hypothalamic ventral medial and arcuate nuclei.
    Gao S; Casals N; Keung W; Moran TH; Lopaschuk GD
    Physiol Behav; 2013 Jun; 118():165-70. PubMed ID: 23680429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase.
    Laurent G; German NJ; Saha AK; de Boer VC; Davies M; Koves TR; Dephoure N; Fischer F; Boanca G; Vaitheesvaran B; Lovitch SB; Sharpe AH; Kurland IJ; Steegborn C; Gygi SP; Muoio DM; Ruderman NB; Haigis MC
    Mol Cell; 2013 Jun; 50(5):686-98. PubMed ID: 23746352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance.
    Samokhvalov V; Ussher JR; Fillmore N; Armstrong IK; Keung W; Moroz D; Lopaschuk DG; Seubert J; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1459-68. PubMed ID: 23074239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
    Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular leptin administration differentially alters cardiac energy metabolism in mice fed a low-fat and high-fat diet.
    Keung W; Cadete VJ; Palaniyappan A; Jablonski A; Fischer M; Lopaschuk GD
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):103-13. PubMed ID: 20980918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.
    Liu Y; He Y; Jin A; Tikunov AP; Zhou L; Tollini LA; Leslie P; Kim TH; Li LO; Coleman RA; Gu Z; Chen YQ; Macdonald JM; Graves LM; Zhang Y
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2414-22. PubMed ID: 24872453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
    Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
    Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel tubulin polymerization inhibitor MHPT exhibits selective anti-tumor activity against rhabdomyosarcoma in vitro and in vivo.
    Mu Y; Liu Y; Li L; Tian C; Zhou H; Zhang Q; Yan B
    PLoS One; 2015; 10(3):e0121806. PubMed ID: 25811876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
    Zhou W; Tu Y; Simpson PJ; Kuhajda FP
    Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
    Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
    Alam N; Saggerson ED
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
    Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.